CYP Design Ltd. (CDL) is dedicated to supporting your research and development needs by offering you stabilised, highly active cytochrome
CYP Design Ltd. (CDL) is dedicated to supporting your research and development needs by offering you stabilised, highly active cytochrome P450 (CYP) products, presented in our unique 'Sacchrosomes™'. These products will satisfy your requirements for quality in early stage testing for new drug discovery, and provide greater convenience due to their stability at room temperature. We also offer reliable contract research services in metabolism and toxicity testing and in biocatalysis.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 14, 2015 | Seed | £50K | 1 | Mercia Fund Managers | — | Detail |
Oct 22, 2013 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mercia Fund Managers | Yes | Seed |